| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d84e6c5464251ca2577721d370ec2c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aed369625281417ecb89f62ea91b9e08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1c0fdd9bbcbee15d88b747e39ccf6d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b62052129b3c4d7febfe7990b116ddc0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 |
| filingDate |
2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d990cd4e292ba43ab2aca19c2f266dfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e290b5e5e2ac8f0b63cbc05da674e42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37b8676ac344b805b743d4ec3e00ff13 |
| publicationDate |
2007-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007038112-A2 |
| titleOfInvention |
Combination of rosiglitazone and donepezil for improvement of cognitive function |
| abstract |
The invention relates inter alia to a pharmaceutical composition comprising both rosiglitazone or a pharmaceutically acceptable salt thereof and donepezil or a pharmaceutically acceptable salt thereof which is of use in the treatment or prophylaxis of Alzheimer's disease or other dementias and mild cognitive impairment. The invention also relates to oral dosage forms comprising rosiglitazone or a pharmaceutically acceptable salt thereof and donepezil or a pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179375-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2987489-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9724339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009095265-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036678-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036678-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009043593-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9907789-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9102666-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10865449-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846315-B2 |
| priorityDate |
2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |